{"title":"Body Pharm","description":"","products":[{"product_id":"bodypharm-semaglutide-6mg","title":"BodyPharm Semaglutide 6mg","description":"\u003cp\u003e\u003cstrong\u003eBP Semaglutide 6 Pen (6mg Semaglutide)\u003c\/strong\u003e, a medication belonging to the class of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), primarily treats type 2 diabetes mellitus by controlling blood sugar levels.\u003c\/p\u003e\n\u003cp\u003eBenefits of Semaglutide:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eBlood Sugar Control:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eSemaglutide mimics GLP-1, regulating blood sugar levels. It prompts insulin release when blood sugar is high and reduces glucagon production, which raises blood sugar.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeight Management:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eSemaglutide promotes weight loss by increasing satiety, reducing food intake, and aiding in weight reduction.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardiovascular Benefits:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eSome studies suggest Semaglutide may reduce the risk of heart-related complications in type 2 diabetes.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eDosage Instructions: Dosages of BP Semaglutide 6 Pen vary based on the product and its use (diabetes or obesity).\u003c\/p\u003e\n\u003cp\u003eSemaglutide is a subcutaneous injection.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eGeneral guidelines are as follows:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFor diabetes management, start with 0.25 mg once a week. Depending on the response and tolerance, increase to 0.5 mg or 1 mg once a week upwards of a maximum 2mg per week.\u003c\/li\u003e\n\u003cli\u003eFor obesity treatment, the recommended dose is 2 mg once a week, administered on the same day weekly, at a time of your choosing.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAlways adhere to your healthcare provider’s dosage instructions, tailored to your specific condition and response.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eWhile not universal, Semaglutide may have side effects:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003eGastrointestinal Issues: Nausea, vomiting, diarrhea, and abdominal pain, especially when starting, may improve over time.\u003c\/li\u003e\n\u003cli\u003eHypoglycemia: Semaglutide has a lower risk of causing low blood sugar compared to some diabetes drugs, but it can still occur, particularly when used with other blood sugar-lowering medications.\u003c\/li\u003e\n\u003cli\u003eInjection Site Reactions: Some individuals may experience redness, itching, or pain at the injection site.\u003c\/li\u003e\n\u003cli\u003ePancreatitis: Pancreas inflammation has been reported as a potential side effect although it is a rare side effect.\u003c\/li\u003e\n\u003cli\u003eKidney Function: Semaglutide may affect kidney function, requiring monitoring in some cases.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eDiscuss potential side effects and concerns with your healthcare provider when considering Semaglutide treatment.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHalf-life:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eBP Semaglutide  boasts a relatively lengthy half-life of about one week, allowing for once-weekly dosing. This extended action duration contributes to its efficacy in managing blood sugar and promoting weight loss.\u003c\/p\u003e\n\u003cp\u003eIn summary, Semaglutide effectively manages type 2 diabetes and aids in weight loss. It provides multiple advantages, including blood sugar control and weight management. However, like all medications, it may cause side effects, and proper dosing guidance should be followed under healthcare provider supervision.\u003c\/p\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43182770716785,"sku":null,"price":2000.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-04-29104413.png?v=1777452152"},{"product_id":"bodypharm-cagrisema-pen-12-mg-pen","title":"BodyPharm Cagrisema PEN 12 MG PEN","description":"\u003ch3 class=\"google-anno-skip google-anno-sc\" role=\"link\" aria-label=\"Buy vitamins and supplements\" data-google-vignette=\"false\" data-google-interstitial=\"false\" tabindex=\"0\"\u003e\u003cstrong\u003eWhat is Cagrisema?\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eCagrisema combines two clinically researched compounds:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSemaglutide (GLP-1)\u003c\/strong\u003e – slows gastric emptying, regulates appetite, reduces cravings, and helps maintain stable blood sugar after meals.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCagrilintide (Amylin analogue)\u003c\/strong\u003e – promotes satiety, regulates appetite, supports insulin control, and aids fat loss.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTogether, these compounds mimic natural metabolic hormones and have been shown in studies to help participants lose up to \u003cstrong\u003e22.5% of their body weight\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch3\u003eKey Benefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePromotes \u003cstrong\u003eeffective and sustainable weight loss\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eHelps \u003cstrong\u003econtrol appetite\u003c\/strong\u003e and reduce food cravings\u003c\/li\u003e\n\u003cli\u003eImproves \u003cstrong\u003eblood sugar regulation\u003c\/strong\u003e for better metabolic health\u003c\/li\u003e\n\u003cli\u003eConvenient \u003cstrong\u003eonce-weekly pre-filled pen\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eSupports long-term weight management and lifestyle change\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eDosage \u0026amp; Usage Guide\u003c\/h3\u003e\n\u003cp\u003eThe \u003cstrong\u003eCagrisema 12mg Pen\u003c\/strong\u003e features a built-in dosage selector for gradual adjustment:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 1–4:\u003c\/strong\u003e 0.25mg\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 5–8:\u003c\/strong\u003e 0.5mg\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 9–12:\u003c\/strong\u003e 0.75mg\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeek 13–16:\u003c\/strong\u003e 1mg\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFrom Week 17 onwards:\u003c\/strong\u003e 1.2mg\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"google-auto-placed\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cp\u003eThis slow increase ensures optimal tolerance and effectiveness. Continue at a dosage that works well for you, as long as appetite control and weight loss progress are maintained.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eWhy Choose Body Pharm Cagrisema?\u003c\/h3\u003e\n\u003cp\u003eWith Body Pharm, you are assured of \u003cstrong\u003ehigh purity peptides, precision dosing, and reliable quality\u003c\/strong\u003e. The Cagrisema 12mg Pen offers South Africans access to advanced weight management technology that works in harmony with a healthy lifestyle for lasting results.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eDisclaimer: This product is investigational and intended for research and personal use under professional guidance. It is not yet approved as a standard medical treatment.\u003c\/em\u003e\u003c\/p\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43182781628529,"sku":null,"price":2300.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-04-29104539.png?v=1777452253"},{"product_id":"bodypharm-tirzepatide-pen-30mg","title":"BodyPharm Tirzepatide PEN 30mg","description":"\u003cp\u003e\u003cstrong\u003eBP Tirzepatide 30 Pen (30mg Tirzepatide)\u003c\/strong\u003e, this medication is the first dual GIP\/\u003cem\u003eGLP\u003c\/em\u003e-1 receptor co-agonist approved for the treatment of type 2 diabetes\u003c\/p\u003e\n\u003cp\u003eTirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, recently developed and finally approved in May 2022 by the Food and Drug Administration for the treatment of T2DM as an adjunct to diet and exercise. In subjects with T2DM, dual GIP and GLP-1 receptor agonism with tirzepatide, compared to single GLP-1 receptor agonism with semaglutide, produced significantly more significant improvements in total insulin secretion rate and insulin sensitivity, reflecting a significant improvement compared to semaglutide.\u003c\/p\u003e\n\u003cp\u003eSimilar effects were also documented in another mechanistic trial comparing tirzepatide with dulaglutide, another GLP-1 receptor agonist, suggesting that dual receptor agonism might indeed be responsible for improving insulin sensitivity, especially since the observed effect was shown to be only partially attributable to weight loss. Furthermore, the effect of tirzepatide on delayed gastric emptying is comparable to that induced by single GLP-1 receptor agonism.\u003c\/p\u003e\n\u003cp\u003eBenefits of Tirzepatide:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eBlood Sugar Control:\u003c\/strong\u003e Tirzepatide mimics GLP-1 and GLI, regulating blood sugar levels. It prompts insulin release when blood sugar is high and reduces glucagon production, which raises blood sugar.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeight Management:\u003c\/strong\u003e Tirzepatide promotes weight loss by increasing satiety, reducing food intake, and aiding in weight reduction.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardiovascular Benefits:\u003c\/strong\u003e Some studies suggest Tirzepatide may reduce the risk of heart-related complications in type 2 diabetes.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eDosage Instructions: Dosages of BP Tirzepatide 30 Pen vary based on the product and its use (diabetes or obesity).\u003c\/p\u003e\n\u003cp\u003eTirzepatide is a subcutaneous injection.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eGeneral guidelines are as follows:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eFor diabetes management, start with 2.5 mg once a week. Depending on the response and tolerance, increase to 5 mg or 7.5 mg once a week upwards of a maximum 15 mg per week.\u003c\/li\u003e\n\u003cli\u003eFor obesity treatment, the recommended dose is 5 mg once a week, administered on the same day weekly, at a time of your choosing.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAlways adhere to your healthcare provider’s dosage instructions, tailored to your specific condition and response.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e While not universal, Tirzepatide may have side effects:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003eGastrointestinal Issues: Nausea, vomiting, diarrhea, and abdominal pain, especially when starting, may improve over time.\u003c\/li\u003e\n\u003cli\u003eHypoglycemia: Tirzepatide has a lower risk of causing low blood sugar compared to some diabetes drugs, but it can still occur, particularly when used with other blood sugar-lowering medications.\u003c\/li\u003e\n\u003cli\u003eInjection Site Reactions: Some individuals may experience redness, itching, or pain at the injection site.\u003c\/li\u003e\n\u003cli\u003ePancreatitis: Pancreas inflammation has been reported as a potential side effect although it is a rare side effect.\u003c\/li\u003e\n\u003cli\u003eKidney Function: Tirzepatide may affect kidney function, requiring monitoring in some cases.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eDiscuss potential side effects and concerns with your healthcare provider when considering Tirzepatide treatment.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHalf-life:\u003c\/strong\u003e BP Tirzepatide  boasts a relatively lengthy half-life of about one week, allowing for once-weekly dosing. This extended action duration contributes to its efficacy in managing blood sugar and promoting weight loss.\u003c\/p\u003e\n\u003cp\u003eIn summary, Tirzepatide effectively manages type 2 diabetes and aids in weight loss. It provides multiple advantages, including blood sugar control and weight management. However, like all medications, it may cause side effects, and proper dosing guidance should be followed under healthcare provider supervision.\u003c\/p\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43182810529905,"sku":null,"price":2500.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-04-29104825.png?v=1777452397"},{"product_id":"bodypharm-retratrutide-pen-32mg","title":"BodyPharm Retratrutide PEN 32mg","description":"\u003cp\u003e\u003cimg\u003e\u003cimg\u003e\u003c\/p\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003eRetatrutide\u003c\/span\u003e is a medicine for weight loss and weight maintenance that contains the active substance Retatrutide. It is similar to a natural hormone called glucagon-like peptide-1 (GLP-1) that is released from the intestine after a meal. Retatrutide works by acting on receptors in the brain that control your appetite, causing you to feel fuller and less hungry and experience less craving for food. This will help you eat less food and reduce your body weight. Retatrutide should be used with a reduced-calorie meal plan and increased physical activity.\u003c\/p\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003eUnique Properties of Retatrutide:\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"s10\"\u003e\n\u003cspan class=\"s9\"\u003e● \u003c\/span\u003e\u003cspan class=\"s6\"\u003eTriple Hormone Agonist:\u003c\/span\u003e Retatrutide is a novel, triple hormone agonist that simultaneously activates the GLP-1, GIP, and glucagon receptors. This unique mechanism offers superior appetite suppression and enhanced energy expenditure compared to traditional GLP-1 receptor agonists.\u003c\/div\u003e\n\u003cdiv class=\"s11\"\u003e\n\u003cspan class=\"s9\"\u003e● \u003c\/span\u003e\u003cspan class=\"s6\"\u003eLong-lasting Effects:\u003c\/span\u003e Retatrutide has a longer half-life, which allows for more stable blood levels and more consistent weight loss results.\u003c\/div\u003e\n\u003cdiv class=\"s12\"\u003e\n\u003cspan class=\"s9\"\u003e● \u003c\/span\u003e\u003cspan class=\"s6\"\u003eEnhanced Metabolic Benefits:\u003c\/span\u003e In addition to weight loss, Retatrutide improves metabolic parameters such as blood glucose levels, making it particularly effective for patients with type 2 diabetes or metabolic syndrome.\u003c\/div\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003eWhat Retatrutide is used for:\u003c\/span\u003e Retatrutide is used for weight loss and weight maintenance in addition to diet and physical activity in adults who have:\u003c\/p\u003e\n\u003cdiv class=\"s10\"\u003e\n\u003cspan class=\"s9\"\u003e● \u003c\/span\u003eA BMI of 30 kg\/m² or greater (with obesity) or\u003c\/div\u003e\n\u003cdiv class=\"s12\"\u003e\n\u003cspan class=\"s9\"\u003e● \u003c\/span\u003eA BMI of 27 kg\/m² and less than 30 kg\/m² (overweight) and weight-related health problems.\u003c\/div\u003e\n\u003cp class=\"s8\"\u003eBMI (Body Mass Index) is a measure of your weight in relation to your height.\u003c\/p\u003e\n\u003cp class=\"s13\"\u003e\u003ca name=\"_tpv9msgk5zxr\"\u003e\u003c\/a\u003e\u003cspan class=\"s4\"\u003e\u003cspan class=\"bumpedFont15\"\u003e2. What you need to know before you use Retatrutide\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003eDo not use Retatrutide if you:\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"s14\"\u003e\n\u003cspan class=\"s9\"\u003e● \u003c\/span\u003eAre allergic to Retatrutide or any of the other ingredients of this medicine (listed in section 6).\u003c\/div\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003eWarnings and precautions:\u003c\/span\u003e Talk to your doctor, pharmacist, or nurse before using Retatrutide or during treatment if you have:\u003c\/p\u003e\n\u003cdiv class=\"s10\"\u003e\n\u003cspan class=\"s9\"\u003e● \u003c\/span\u003e\u003cspan class=\"s6\"\u003eEffects on the digestive system:\u003c\/span\u003e You may feel sick (nausea), be sick (vomiting), or have diarrhea. These side effects can cause dehydration (loss of fluids). It is important that you drink enough fluids to prevent dehydration. This is especially important if you have kidney problems. Talk to your doctor if you have any questions or concerns.\u003c\/div\u003e\n\u003cdiv class=\"s11\"\u003e\n\u003cspan class=\"s9\"\u003e● \u003c\/span\u003e\u003cspan class=\"s6\"\u003eInflammation of the pancreas:\u003c\/span\u003e If you have severe and ongoing pain in the stomach area, see a doctor straight away as this could be a sign of an inflamed pancreas (acute pancreatitis).\u003c\/div\u003e\n\u003cdiv class=\"s11\"\u003e\n\u003cspan class=\"s9\"\u003e● \u003c\/span\u003e\u003cspan class=\"s6\"\u003eDiabetes:\u003c\/span\u003e Retatrutide must not be used as a substitute for insulin.\u003c\/div\u003e\n\u003cdiv class=\"s11\"\u003e\n\u003cspan class=\"s9\"\u003e● \u003c\/span\u003e\u003cspan class=\"s6\"\u003eLow blood sugar (hypoglycemia):\u003c\/span\u003e Taking a sulfonylurea or insulin with Retatrutide might increase the risk of getting low blood sugar levels (hypoglycemia). Please see section 4 for the warning signs of low blood sugar levels. Your doctor may ask you to test your blood sugar levels. This will help your doctor decide if the dose of the sulfonylurea or insulin needs to be changed to reduce the risk of low blood sugar.\u003c\/div\u003e\n\u003cdiv class=\"s12\"\u003e\n\u003cspan class=\"s9\"\u003e● \u003c\/span\u003e\u003cspan class=\"s6\"\u003eDiabetic eye disease (retinopathy):\u003c\/span\u003e Fast improvements in blood sugar control may lead to a temporary worsening of diabetic eye disease. If you have diabetic eye disease and experience eye problems while taking this medicine, talk to your doctor.\u003c\/div\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003eChildren and adolescents:\u003c\/span\u003e This medicine is not recommended in children and adolescents under 18 years as there is no information on use in children below this age.\u003c\/p\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003eOther medicines and Retatrutide:\u003c\/span\u003e Tell your doctor, pharmacist, or nurse if you are using, have recently used, or might use any other medicines.\u003c\/p\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003ePregnancy and breastfeeding:\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"s10\"\u003e\n\u003cspan class=\"s9\"\u003e● \u003c\/span\u003eThis medicine should not be used during pregnancy, as it is not known if it may affect your unborn child. Therefore, it is recommended to use contraception while using this medicine. If you wish to become pregnant, you should stop using this medicine at least two months in advance. If you become or are pregnant, think you may be pregnant or are planning to have a baby when using this medicine, talk to your doctor straight away, as your treatment will need to be stopped.\u003c\/div\u003e\n\u003cdiv class=\"s12\"\u003e\n\u003cspan class=\"s9\"\u003e● \u003c\/span\u003eYou should not use this medicine if you are breastfeeding, as it is unknown if it passes into breast milk.\u003c\/div\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003eDriving and using machines:\u003c\/span\u003e Retatrutide is unlikely to affect your ability to drive and use machines. Some patients may feel dizzy when taking Retatrutide, mainly during the first 3 months of treatment (see section 4). If you feel dizzy, you should not drive or operate machines until you feel better. If you need any further information, talk to your doctor, pharmacist, or nurse.\u003c\/p\u003e\n\u003cp class=\"s8\"\u003eFor diabetics using this medicine in combination with a sulfonylurea or insulin, low blood sugar (hypoglycemia) may occur, which may reduce your ability to concentrate. Do not drive or use machines if you get any signs of low blood sugar. See section 2, ‘Warnings and precautions,’ for information on increased risk of low blood sugar and section 4 for the warning signs of low blood sugar. Talk to your doctor for further information.\u003c\/p\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003eSodium content:\u003c\/span\u003e This pen contains less than 1 mmol sodium (23 mg) per dose, i.e., essentially ‘sodium-free’.\u003c\/p\u003e\n\u003cp class=\"s13\"\u003e\u003ca name=\"_3d00ogf7nb8\"\u003e\u003c\/a\u003e\u003cspan class=\"s4\"\u003e\u003cspan class=\"bumpedFont15\"\u003e3. How to use Retatrutide\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"s8\"\u003eAlways use this medicine exactly as your doctor has told you. Check with your doctor, pharmacist, or nurse if you are not sure.\u003c\/p\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003eHow much to use:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"s8\"\u003eThe recommended therapeutic long-term dosage is 8 mg weekly for weight loss purposes. Some users can tolerate higher dosages; please seek guidance from your practitioner if higher-than-recommended dosages are to be followed.\u003c\/p\u003e\n\u003cp class=\"s8\"\u003eYour treatment will start at a low dose, which will be gradually increased over 16 weeks of treatment as follows:\u003c\/p\u003e\n\u003cp class=\"s8\"\u003eWhen you first start using Retatrutide, the starting dose is 2 mg once weekly. Your practitioner will instruct you to gradually increase your dose every 4 weeks until you reach the recommended dose of 8 mg once weekly. Your practitioner may decide to keep you at a lower maintenance dosage. Once you reach the recommended dose of 8 mg, do not increase this dose further unless under the guidance of a practitioner. You will be told to follow the table below.\u003c\/p\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003eDose escalation:\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv class=\"rte-table-wrapper\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd class=\"s15\"\u003e\n\u003cdiv\u003e\n\u003cp class=\"s16\"\u003e\u003cspan class=\"s6\"\u003eWeek\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd class=\"s15\"\u003e\n\u003cdiv\u003e\n\u003cp class=\"s16\"\u003e\u003cspan class=\"s6\"\u003eWeekly Dose\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd class=\"s15\"\u003e\n\u003cdiv\u003e\n\u003cp class=\"s16\"\u003e\u003cspan class=\"s6\"\u003eUnits to Inject\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"s15\"\u003e\n\u003cdiv\u003e\n\u003cp\u003eWeek 1-4\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd class=\"s15\"\u003e\n\u003cdiv\u003e\n\u003cp\u003e2 mg\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd class=\"s15\"\u003e\n\u003cdiv\u003e\n\u003cp\u003e2 mg marker on dosage selector\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"s15\"\u003e\n\u003cdiv\u003e\n\u003cp\u003eWeek 5-8\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd class=\"s15\"\u003e\n\u003cdiv\u003e\n\u003cp\u003e4 mg\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd class=\"s15\"\u003e\n\u003cdiv\u003e\n\u003cp\u003e4 mg marker on dosage selector\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"s15\"\u003e\n\u003cdiv\u003e\n\u003cp\u003eWeek 9-12\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd class=\"s15\"\u003e\n\u003cdiv\u003e\n\u003cp\u003e8 mg\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd class=\"s15\"\u003e\n\u003cdiv\u003e\n\u003cp\u003e8 mg marker on dosage selector\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd class=\"s15\"\u003e\n\u003cdiv\u003e\n\u003cp\u003eFrom Week 13\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd class=\"s15\"\u003e\n\u003cdiv\u003e\n\u003cp\u003e12 mg\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd class=\"s15\"\u003e\n\u003cdiv\u003e\n\u003cp\u003e8 mg + 4 mg marker on dosage selector\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003cp class=\"s8\"\u003e*Body Pharm Retatrutide pen can be dosed to 8 mg by using the 8 mg marker on the dosage selector. Seek guidance from your practitioner as alternative dosing schedules are not covered in the scope of this leaflet.\u003c\/p\u003e\n\u003cp class=\"s8\"\u003eYour practitioner will assess your treatment on a regular basis.\u003c\/p\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003eHow Retatrutide is given:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"s8\"\u003eRetatrutide is given as an injection under the skin (subcutaneous injection). Do not inject it into a vein or muscle. The best places to give the injection are the upper arms, stomach, or upper legs. Before you use the pen for the first time, ask your doctor or nurse how to use it. Detailed instructions for use are on the other side of this leaflet.\u003c\/p\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003ePeople with diabetes:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"s8\"\u003eTell your doctor if you have diabetes. Your doctor may adjust the dose of your diabetes medicines to prevent you from getting low blood sugar. Do not mix Retatrutide with other medicines that you inject (e.g., insulins). Do not use Retatrutide in combination with other medicines that contain GLP-1 receptor agonists.\u003c\/p\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003eWhen to use Retatrutide:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"s8\"\u003eYou should use this medicine once a week and, if possible, on the same day each week. You can give yourself the injection at any time of the day, regardless of meals. If necessary, you can change the day of your weekly injection of this medicine as long as it has been at least 3 days since your last injection. After selecting a new dosing day, continue with once-a-week dosing.\u003c\/p\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003eIf you use more Retatrutide than you should:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"s8\"\u003eTalk to your doctor straight away. You may get side effects such as feeling sick (nausea).\u003c\/p\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003eIf you forget to use Retatrutide:\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"s8\"\u003eIf you forgot to inject a dose and:\u003c\/p\u003e\n\u003cdiv class=\"s10\"\u003e\n\u003cspan class=\"s9\"\u003e● \u003c\/span\u003eIt is 5 days or less since you should have used Retatrutide, use it as soon as you remember. Then inject your next dose as usual on your scheduled day.\u003c\/div\u003e\n\u003cdiv class=\"s11\"\u003e\n\u003cspan class=\"s9\"\u003e● \u003c\/span\u003eIt is more than 5 days since you should have used Retatrutide, skip the missed dose. Then inject your next dose as usual on your scheduled day.\u003c\/div\u003e\n\u003cdiv class=\"s12\"\u003e\n\u003cspan class=\"s9\"\u003e● \u003c\/span\u003eDo not take an extra dose or increase the dose to make up for the missed dose.\u003c\/div\u003e\n\u003cp class=\"s8\"\u003e\u003cspan class=\"s6\"\u003eIf you stop using Retatrutide:\u003c\/span\u003e Do not stop using Retatrutide without talking to your doctor. If you stop using Retatrutide, your appetite may increase, and your weight may increase.\u003c\/p\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43182822522993,"sku":null,"price":3100.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-04-29104937.png?v=1777452475"},{"product_id":"bodypharm-bpc-157-tb500-32mg","title":"BodyPharm BPC 157 \u0026 TB500 32mg","description":"\u003ch1\u003e\u003cstrong\u003eBP BPC-157 \u0026amp; TB-500 32\u003c\/strong\u003e\u003c\/h1\u003e\n\u003cp\u003eBPC-157 \u0026amp; TB-500 32 is a dual-peptide injectable research compound containing\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e32 mg total per pen\u003c\/strong\u003e, made up of\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e16 mg BPC-157\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eand\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e16 mg TB-500\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eThe prefilled pen allows\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eprecise dose selection\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eof\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e0.25 mg, 0.5 mg, 0.75 mg, or 1 mg\u003c\/strong\u003e, delivering\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eequal amounts of each peptide per dose\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003efor controlled administration under research or practitioner guidance.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor research use only.\u003c\/strong\u003e\u003cbr\u003eTo be handled by qualified professionals in appropriate settings.\u003c\/p\u003e\n\u003ch2\u003e\u003cbr\u003e\u003c\/h2\u003e\n\u003ch2\u003e\u003cstrong\u003eWhat BPC-157 \u0026amp; TB-500 32 Is Used For\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eThis compound combines two regenerative research peptides:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e— a stomach-derived pentadecapeptide studied for tissue repair, angiogenesis, and inflammation modulation.\u003cbr\u003e\u003cstrong\u003eTB-500 (Thymosin Beta-4 fragment)\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e— a synthetic peptide associated with cell migration, regeneration, and wound healing.\u003c\/p\u003e\n\u003ch3\u003e\u003cem\u003e(Key Research Focus Areas)\u003c\/em\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eMuscle, tendon, ligament, and joint recovery\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eInflammation reduction\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eVascular and connective tissue support\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eSoft-tissue repair under physical stress\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eImproved mobility and post-injury recovery\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe combined use of BPC-157 and TB-500 provides a\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003esynergistic regenerative effect\u003c\/strong\u003e, supporting faster recovery and systemic tissue repair.\u003c\/p\u003e\n\u003ch2\u003e\u003cbr\u003e\u003c\/h2\u003e\n\u003ch2\u003e\u003cstrong\u003eImportant Information Before Use\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cstrong\u003eDo Not Use If You\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eAre allergic to either peptide or formulation components\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eAre pregnant or breastfeeding\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eAre not trained in peptide handling or injection protocols\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cbr\u003e\u003c\/h2\u003e\n\u003ch2\u003e\u003cstrong\u003eHow to Use BPC-157 \u0026amp; TB-500 32\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eUse this product\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eonly as instructed\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eby your research protocol or supervising practitioner.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAdministration Route:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eSubcutaneous injection via prefilled pen.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eDosage Information\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eTotal per pen:\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e32 mg (16 mg of each peptide)\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eSelectable doses:\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e0.25 mg \/ 0.5 mg \/ 0.75 mg \/ 1 mg\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eExample: A\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e0.5 mg\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003edose delivers\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e0.5 mg BPC-157 + 0.5 mg TB-500\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eInjection Sites\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eAbdomen (minimum 5 cm from the navel)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eOuter thigh\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eBack of the upper arm\u003cbr\u003eRotate injection sites to reduce irritation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cbr\u003e\u003c\/h2\u003e\n\u003ch2\u003e\u003cstrong\u003eSuggested Research Dosage Guidelines\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\n\u003cdiv class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eApplication Area\u003c\/th\u003e\n\u003cth\u003eSuggested Dose\u003c\/th\u003e\n\u003cth\u003eFrequency\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eInjury Recovery\u003c\/td\u003e\n\u003ctd\u003e0.75 – 1 mg\u003c\/td\u003e\n\u003ctd\u003eDaily\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eJoint \u0026amp; Tendon Inflammation\u003c\/td\u003e\n\u003ctd\u003e0.5 – 0.75 mg\u003c\/td\u003e\n\u003ctd\u003eDaily\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGut \/ GI Research\u003c\/td\u003e\n\u003ctd\u003e0.25 – 0.5 mg\u003c\/td\u003e\n\u003ctd\u003eDaily\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePost-Surgical Recovery\u003c\/td\u003e\n\u003ctd\u003e1 mg\u003c\/td\u003e\n\u003ctd\u003eDaily\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGeneral Regeneration\u003c\/td\u003e\n\u003ctd\u003e0.5 – 0.75 mg\u003c\/td\u003e\n\u003ctd\u003eDaily or 5× weekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003eMissed Dose:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eAdminister as soon as possible. Do not double doses.\u003cbr\u003e\u003cstrong\u003eOverdose:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eHigh doses may cause fatigue or mild nausea. Seek professional guidance if needed.\u003c\/p\u003e\n\u003ch2\u003e\u003cbr\u003e\u003c\/h2\u003e\n\u003ch2\u003e\u003cstrong\u003ePossible Side Effects\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cstrong\u003eCommon\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eMild injection-site irritation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eFatigue\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eHeadache\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eLess Common\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eNausea\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eTemporary flushing\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43182907162737,"sku":null,"price":1800.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-04-29110250.png?v=1777453292"},{"product_id":"body-pharm-hcg-5000-iu-vial","title":"Body Pharm - HCG 5000 IU | Vial","description":"\u003ch1\u003e\u003cstrong\u003eBP HCG 5000 IU (Human Chorionic Gonadotropin)\u003c\/strong\u003e\u003c\/h1\u003e\n\u003cp\u003eHCG 5000 IU is a peptide hormone formulation containing\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e5,000 international units of Human Chorionic Gonadotropin\u003c\/strong\u003e. HCG is a naturally occurring hormone with well-documented applications in fertility, hormonal support, and endocrine research.\u003c\/p\u003e\n\u003cp\u003eThis compound is commonly utilized in both male and female protocols where hormonal signaling, gonadal function, or endocrine balance is required.\u003c\/p\u003e\n\u003ch2\u003e\u003cbr\u003e\u003c\/h2\u003e\n\u003ch2\u003e\u003cstrong\u003eWhat HCG 5000 IU Is Used For\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eHCG is commonly associated with support for:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eFertility treatments in men and women\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eStimulation of ovulation in females\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eSupport of sperm production in males\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eMaintenance of testosterone production in men\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eHormonal balance following anabolic steroid use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eMetabolic and fat-loss support in structured protocols\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIts versatility makes HCG a widely used hormone in both clinical and performance-related settings.\u003c\/p\u003e\n\u003ch2\u003e\u003cbr\u003e\u003c\/h2\u003e\n\u003ch2\u003e\u003cstrong\u003eHow HCG Works\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eHCG works by mimicking luteinizing hormone (LH), signaling the gonads to produce sex hormones.\u003c\/p\u003e\n\u003cp\u003eKey characteristics include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eStimulation of testosterone production in men\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eSupport of ovarian follicle maturation and ovulation in women\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eMaintenance of testicular function during hormonal suppression\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eTypical half-life of approximately\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e24–36 hours\u003c\/strong\u003e, allowing sustained biological activity\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThis mechanism allows HCG to remain active in the body for extended periods after administration.\u003c\/p\u003e\n\u003ch2\u003e\u003cbr\u003e\u003c\/h2\u003e\n\u003ch2\u003e\u003cstrong\u003eHow to Use HCG 5000 IU\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eUse this product only as directed by a healthcare professional or supervising practitioner.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAdministration Route:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eSubcutaneous injection.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eDosage Information\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eDosage varies depending on application and individual response:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eFertility (Women):\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eCommonly\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e5,000–10,000 IU\u003c\/strong\u003e, administered following follicle-stimulating hormone protocols\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eFertility (Men):\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eTypically\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e1,000–4,000 IU\u003c\/strong\u003e, injected\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e2–3 times per week\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eWeight-management protocols:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eOften\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e125–250 IU per day\u003c\/strong\u003e, used alongside structured dietary plans\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eDosage should always be individualized and guided by professional supervision.\u003c\/p\u003e\n\u003ch2\u003e\u003cbr\u003e\u003c\/h2\u003e\n\u003ch2\u003e\u003cstrong\u003ePossible Side Effects\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eLike all hormone-based compounds, HCG may cause side effects, although not everyone will experience them.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eCommon\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eMild injection-site irritation (redness or swelling)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eFluid retention\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eHormonal fluctuations, including mood changes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eLess Common\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eBreast tenderness\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eHeadache or fatigue\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43182909096049,"sku":null,"price":590.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-04-29110509.png?v=1777453422"},{"product_id":"bodypharm-tirzepatide-pen-60mg-1","title":"BodyPharm Tirzepatide PEN 60mg","description":"\u003cp data-start=\"440\" data-end=\"620\"\u003eTirzepatide is a peptide studied extensively for its activity across key metabolic and incretin pathways. It functions as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"583\" data-end=\"608\"\u003edual receptor agonist\u003c\/strong\u003e, acting on:\u003c\/p\u003e\n\u003cul data-start=\"622\" data-end=\"736\"\u003e\n\u003cli data-start=\"622\" data-end=\"669\"\u003e\n\u003cp data-start=\"624\" data-end=\"669\"\u003e\u003cstrong data-start=\"624\" data-end=\"669\"\u003eGLP-1 (glucagon-like peptide-1) receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"670\" data-end=\"736\"\u003e\n\u003cp data-start=\"672\" data-end=\"736\"\u003e\u003cstrong data-start=\"672\" data-end=\"736\"\u003eGIP (glucose-dependent insulinotropic polypeptide) receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"738\" data-end=\"939\"\u003eThrough this dual mechanism, tirzepatide has been investigated for its effects on insulin secretion, regulation of hepatic glucose production, delayed gastric emptying, and appetite-related signalling.\u003c\/p\u003e\n\u003cp data-start=\"941\" data-end=\"1136\"\u003eThis product is supplied as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"298\" data-start=\"269\"\u003epre-filled injectable pen\u003c\/strong\u003e intended for purchasers who have independently researched the compound and are operating under appropriate professional guidance.\u003c\/p\u003e\n\u003chr data-start=\"1138\" data-end=\"1141\"\u003e\n\u003ch3 data-start=\"1143\" data-end=\"1182\"\u003eClinical Trial Evidence (Phase 3)\u003c\/h3\u003e\n\u003cp data-start=\"1183\" data-end=\"1279\"\u003eTirzepatide has undergone extensive\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1219\" data-end=\"1250\"\u003ePhase 3 clinical evaluation\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ein large, controlled trials.\u003c\/p\u003e\n\u003cul data-start=\"1281\" data-end=\"1735\"\u003e\n\u003cli data-start=\"1281\" data-end=\"1563\"\u003e\n\u003cp data-start=\"1283\" data-end=\"1563\"\u003eIn Phase 3 studies conducted under controlled conditions, tirzepatide demonstrated\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1366\" data-end=\"1421\"\u003esubstantial and sustained reductions in body weight\u003c\/strong\u003e, with participants achieving\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1451\" data-end=\"1524\"\u003eaverage weight reductions of up to approximately 22–23% over 72 weeks\u003c\/strong\u003e, depending on dose and study protocol.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1564\" data-end=\"1735\"\u003e\n\u003cp data-start=\"1566\" data-end=\"1735\"\u003ePhase 3 programmes also evaluated long-term safety, tolerability, and metabolic outcomes, forming the basis for subsequent regulatory approvals in certain jurisdictions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1737\" data-end=\"1882\"\u003eOutcomes observed in clinical trials are dependent on controlled protocols and\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1816\" data-end=\"1881\"\u003edo not guarantee similar results outside of clinical settings\u003c\/strong\u003e.\u003c\/p\u003e\n\u003chr data-start=\"1884\" data-end=\"1887\"\u003e\n\u003ch3 data-start=\"1889\" data-end=\"1919\"\u003eHow Tirzepatide Compares\u003c\/h3\u003e\n\u003cp data-start=\"1920\" data-end=\"1991\"\u003eTirzepatide is often discussed alongside other incretin-based peptides:\u003c\/p\u003e\n\u003cul data-start=\"1993\" data-end=\"2233\"\u003e\n\u003cli data-start=\"1993\" data-end=\"2057\"\u003e\n\u003cp data-start=\"1995\" data-end=\"2057\"\u003e\u003cstrong data-start=\"1995\" data-end=\"2010\"\u003eSemaglutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003efunctions as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2026\" data-end=\"2057\"\u003eGLP-1 receptor agonist only\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2058\" data-end=\"2141\"\u003e\n\u003cp data-start=\"2060\" data-end=\"2141\"\u003e\u003cstrong data-start=\"2060\" data-end=\"2075\"\u003eTirzepatide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2081\" data-end=\"2097\"\u003edual agonist\u003c\/strong\u003e, targeting both\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2114\" data-end=\"2141\"\u003eGLP-1 and GIP receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2142\" data-end=\"2233\"\u003e\n\u003cp data-start=\"2144\" data-end=\"2233\"\u003eThis dual activity differentiates tirzepatide from earlier single-pathway GLP-1 compounds\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2055\" data-start=\"2052\"\u003e\n\u003ch3 data-end=\"2082\" data-start=\"2057\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3 data-end=\"2082\" data-start=\"2057\"\u003eImportant Information\u003c\/h3\u003e\n\u003cul data-end=\"2441\" data-start=\"2083\"\u003e\n\u003cli data-end=\"2145\" data-start=\"2083\"\u003e\n\u003cp data-end=\"2145\" data-start=\"2085\"\u003eSupplied as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"298\" data-start=\"269\"\u003epre-filled injectable pen\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2211\" data-start=\"2146\"\u003e\n\u003cp data-end=\"2211\" data-start=\"2148\"\u003eNo dosing, administration, or medical instructions are provided\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2367\" data-start=\"2266\"\u003e\n\u003cp data-end=\"2367\" data-start=\"2268\"\u003eConsultation with a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2320\" data-start=\"2288\"\u003elicensed healthcare provider\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis essential prior to any consideration of use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2441\" data-start=\"2368\"\u003e\n\u003cp data-end=\"2441\" data-start=\"2370\"\u003eResults observed in clinical trials may not reflect real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2446\" data-start=\"2443\"\u003e\n\u003ch3 data-end=\"2481\" data-start=\"2448\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp data-end=\"2588\" data-start=\"2482\"\u003eThis product is supplied strictly on an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2550\" data-start=\"2522\"\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul data-end=\"3029\" data-start=\"2590\"\u003e\n\u003cli data-end=\"2671\" data-start=\"2590\"\u003e\n\u003cp data-end=\"2671\" data-start=\"2592\"\u003eYou have independently researched this product and its investigational status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2748\" data-start=\"2672\"\u003e\n\u003cp data-end=\"2748\" data-start=\"2674\"\u003eYou have consulted, or will consult, a qualified healthcare professional\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2943\" data-start=\"2860\"\u003e\n\u003cp data-end=\"2943\" data-start=\"2862\"\u003eThe seller provides\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2941\" data-start=\"2882\"\u003eno medical advice, treatment claims, or dosing guidance\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3029\" data-start=\"2944\"\u003e\n\u003cp data-end=\"3029\" data-start=\"2946\"\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"3029\" data-start=\"2950\"\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43251183485041,"sku":null,"price":3100.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-05-18124650.png?v=1779101125"},{"product_id":"bodypharm-retratrutide-pen-64mg","title":"BodyPharm Retratrutide PEN 64mg","description":"\u003cp data-start=\"379\" data-end=\"617\"\u003eRetatrutide is a peptide currently under advanced clinical investigation for its activity across multiple metabolic pathways. It is designed to act on\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"549\" data-end=\"614\"\u003ethree key receptors involved in glucose and energy regulation\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul data-start=\"618\" data-end=\"731\"\u003e\n\u003cli data-start=\"618\" data-end=\"653\"\u003e\n\u003cp data-start=\"620\" data-end=\"653\"\u003eGLP-1 (glucagon-like peptide-1)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"654\" data-end=\"708\"\u003e\n\u003cp data-start=\"656\" data-end=\"708\"\u003eGIP (glucose-dependent insulinotropic polypeptide)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"709\" data-end=\"731\"\u003e\n\u003cp data-start=\"711\" data-end=\"731\"\u003eGlucagon receptors\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"733\" data-end=\"927\"\u003eThrough this\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"746\" data-end=\"774\"\u003etriple-agonist mechanism\u003c\/strong\u003e, retatrutide has been studied for its effects on insulin secretion, regulation of glucose production, gastric emptying, and appetite-related signalling.\u003c\/p\u003e\n\u003chr data-start=\"929\" data-end=\"932\"\u003e\n\u003ch3 data-start=\"934\" data-end=\"959\"\u003eClinical Trial Status\u003c\/h3\u003e\n\u003cp data-start=\"960\" data-end=\"1077\"\u003eAs of\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"966\" data-end=\"974\"\u003e2025\u003c\/strong\u003e, retatrutide remains\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"996\" data-end=\"1052\"\u003eunder investigation and is not yet formally approved\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003efor general medical use.\u003c\/p\u003e\n\u003cul data-start=\"1079\" data-end=\"1534\"\u003e\n\u003cli data-start=\"1079\" data-end=\"1280\"\u003e\n\u003cp data-start=\"1081\" data-end=\"1280\"\u003e\u003cstrong data-start=\"1081\" data-end=\"1109\"\u003ePhase 2 clinical studies\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ereported significant outcomes, with participants experiencing an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1175\" data-end=\"1245\"\u003eaverage body-weight reduction of approximately 24.2% over 48 weeks\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eunder controlled trial conditions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1281\" data-end=\"1534\"\u003e\n\u003cp data-start=\"1283\" data-end=\"1534\"\u003e\u003cstrong data-start=\"1283\" data-end=\"1310\"\u003ePhase 3 clinical trials\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eare ongoing and have reported\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1341\" data-end=\"1422\"\u003econtinued, clinically meaningful effects consistent with earlier trial phases\u003c\/strong\u003e, further evaluating long-term safety, efficacy, and tolerability. Final data and regulatory review are pending.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1536\" data-end=\"1617\"\u003eNo guarantees of outcome can be inferred outside of controlled clinical settings.\u003c\/p\u003e\n\u003chr data-start=\"1619\" data-end=\"1622\"\u003e\n\u003ch3 data-start=\"1624\" data-end=\"1652\"\u003eHow Retatrutide Compares\u003c\/h3\u003e\n\u003cp data-start=\"1653\" data-end=\"1725\"\u003eRetatrutide is often discussed alongside other incretin-based compounds:\u003c\/p\u003e\n\u003cul data-start=\"1727\" data-end=\"2050\"\u003e\n\u003cli data-start=\"1727\" data-end=\"1791\"\u003e\n\u003cp data-start=\"1729\" data-end=\"1791\"\u003e\u003cstrong data-start=\"1729\" data-end=\"1744\"\u003eSemaglutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eacts primarily as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1765\" data-end=\"1791\"\u003eGLP-1 receptor agonist\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1792\" data-end=\"1875\"\u003e\n\u003cp data-start=\"1794\" data-end=\"1875\"\u003e\u003cstrong data-start=\"1794\" data-end=\"1809\"\u003eTirzepatide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1815\" data-end=\"1831\"\u003edual agonist\u003c\/strong\u003e, targeting both\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1848\" data-end=\"1875\"\u003eGLP-1 and GIP receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1876\" data-end=\"2050\"\u003e\n\u003cp data-start=\"1878\" data-end=\"2050\"\u003e\u003cstrong data-start=\"1878\" data-end=\"1893\"\u003eRetatrutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1899\" data-end=\"1917\"\u003etriple agonist\u003c\/strong\u003e, additionally engaging the\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1945\" data-end=\"1966\"\u003eglucagon receptor\u003c\/strong\u003e, which differentiates its investigational profile from earlier-generation compounds\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003chr data-start=\"2052\" data-end=\"2055\"\u003e\n\u003ch3 data-start=\"2057\" data-end=\"2082\"\u003eImportant Information\u003c\/h3\u003e\n\u003cul data-start=\"2083\" data-end=\"2441\"\u003e\n\u003cli data-start=\"2083\" data-end=\"2145\"\u003e\n\u003cp data-start=\"2085\" data-end=\"2145\"\u003eSupplied as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"269\" data-end=\"298\"\u003epre-filled injectable pen\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2212\" data-end=\"2265\"\u003e\n\u003cp data-start=\"2214\" data-end=\"2265\"\u003eRetatrutide remains an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2237\" data-end=\"2265\"\u003einvestigational compound\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2266\" data-end=\"2367\"\u003e\n\u003cp data-start=\"2268\" data-end=\"2367\"\u003eConsultation with a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2288\" data-end=\"2320\"\u003elicensed healthcare provider\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis essential prior to any consideration of use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2368\" data-end=\"2441\"\u003e\n\u003cp data-start=\"2370\" data-end=\"2441\"\u003eResults observed in clinical trials may not reflect real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"2443\" data-end=\"2446\"\u003e\n\u003ch3 data-start=\"2448\" data-end=\"2481\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2482\" data-end=\"2588\"\u003eThis product is supplied strictly on an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2522\" data-end=\"2550\"\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul data-start=\"2590\" data-end=\"3029\"\u003e\n\u003cli data-start=\"2590\" data-end=\"2671\"\u003e\n\u003cp data-start=\"2592\" data-end=\"2671\"\u003eYou have independently researched this product and its investigational status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2672\" data-end=\"2748\"\u003e\n\u003cp data-start=\"2674\" data-end=\"2748\"\u003eYou have consulted, or will consult, a qualified healthcare professional\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2749\" data-end=\"2859\"\u003e\n\u003cp data-start=\"2751\" data-end=\"2859\"\u003eYou understand that retatrutide is\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2786\" data-end=\"2806\"\u003enot yet approved\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eand remains subject to ongoing clinical evaluation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2860\" data-end=\"2943\"\u003e\n\u003cp data-start=\"2862\" data-end=\"2943\"\u003eThe seller provides\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2882\" data-end=\"2941\"\u003eno medical advice, treatment claims, or dosing guidance\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2944\" data-end=\"3029\"\u003e\n\u003cp data-start=\"2946\" data-end=\"3029\"\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2950\" data-end=\"3029\"\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43251185352817,"sku":null,"price":3900.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-05-18124939.png?v=1779101283"},{"product_id":"bodypharm-ghk-cu-50mg-pen","title":"BodyPharm GHK-Cu 50mg Pen","description":"\u003cp\u003eGHK-Cu (\u003ca href=\"https:\/\/en.wikipedia.org\/wiki\/Copper_peptide_GHK-Cu\"\u003eCopper Tripeptide-1\u003c\/a\u003e) is a naturally occurring copper-binding peptide widely studied for its regenerative and protective properties, particularly in skin, hair, and connective tissue health. GHK-Cu 50 is a research-grade peptide presented in a convenient multi-dose subcutaneous injection pen, enabling precise administration in 1mg, 2mg, or 3mg increments.\u003c\/p\u003e\n\u003cp\u003eEach pen contains a total of 50mg of GHK-Cu peptide in a stable solution format. This formulation is designed for ease of use, consistency, and convenience in controlled research settings.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIndications \u0026amp; Use of GHK CU Peptide Pen\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eGHK-Cu has been observed in research to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli aria-level=\"1\"\u003eSupport \u003cb\u003eskin regeneration\u003c\/b\u003e, elasticity, and collagen synthesis\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eEnhance \u003cb\u003ehair growth\u003c\/b\u003e and reduce follicular inflammation\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eImprove \u003cb\u003enail strength and resilience\u003c\/b\u003e\n\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eExhibit \u003cb\u003eanti-inflammatory\u003c\/b\u003e and \u003cb\u003ewound healing\u003c\/b\u003e properties\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003ePromote overall \u003cb\u003etissue repair and cellular renewal\u003c\/b\u003e\u003cb\u003e\u003cbr\u003e\u003c\/b\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cb\u003eMechanism of Action\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eGHK-Cu functions by binding copper ions and modulating several biological processes. It is known to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli aria-level=\"1\"\u003e\n\u003cb\u003eUpregulate genes associated with tissue repair\u003c\/b\u003e, collagen production, and anti-aging\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003e\n\u003cb\u003eDownregulate pro-inflammatory cytokines\u003c\/b\u003e and oxidative stress markers\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eStimulate stem cell activity and \u003cb\u003eangiogenesis\u003c\/b\u003e (formation of new blood vessels)\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eActivate \u003cb\u003eTGF-β and integrin pathways\u003c\/b\u003e, contributing to faster healing and skin renewal\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIts ability to communicate with multiple cell types and influence gene expression sets it apart from other peptides in the regenerative and cosmetic research fields.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eDosage \u0026amp; Administration of GHK CU Peptide Pen\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eEach pen contains 50mg of GHK-Cu in total and is dispensed in:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli aria-level=\"1\"\u003e\n\u003cb\u003e1mg\u003c\/b\u003e, \u003cb\u003e2mg\u003c\/b\u003e, or \u003cb\u003e3mg\u003c\/b\u003e increments\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003e\n\u003cb\u003eSubcutaneous injection\u003c\/b\u003e (typically in the abdomen or thigh area)\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003e\n\u003cb\u003eDosing frequency\u003c\/b\u003e varies depending on research protocol, but is often used daily or every other day\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAlways use sterile technique. Replace the needle after each use. Dosage should align with your specific research goals.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eStorage \u0026amp; Stability\u003c\/b\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli aria-level=\"1\"\u003e\n\u003cb\u003eStore between 2–8°C\u003c\/b\u003e (36–46°F)\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003e\u003cb\u003eProtect from direct sunlight\u003c\/b\u003e\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003e\u003cb\u003eKeep out of reach of children\u003c\/b\u003e\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003e\u003cb\u003eDo not freeze\u003c\/b\u003e\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eOnce opened, use within \u003cb\u003e30 days\u003c\/b\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cb\u003ePossible Side Effects of GHK CU Peptide Pen\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eGHK-Cu is generally well-tolerated in research settings. Potential side effects observed in limited studies include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli aria-level=\"1\"\u003eLocal irritation at injection site (redness, itching, swelling)\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eTemporary fatigue or light-headedness\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eAllergic reaction (rare)\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eCopper overload symptoms if used in excessive doses or combined with other copper-containing agents\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cb\u003eContraindications\u003c\/b\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli aria-level=\"1\"\u003eKnown \u003cb\u003ehypersensitivity to copper compounds or peptides\u003c\/b\u003e\n\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eExisting \u003cb\u003ecopper metabolism disorders\u003c\/b\u003e (e.g., Wilson’s disease)\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003eUse with caution in subjects with \u003cb\u003eliver or kidney impairment\u003c\/b\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cb\u003ePackaging Contents\u003c\/b\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli aria-level=\"1\"\u003e1x \u003cb\u003eGHK-Cu 50mg multi-dose injection pen\u003c\/b\u003e\n\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003e8x sterile \u003cb\u003esingle-use pen needles\u003c\/b\u003e\n\u003c\/li\u003e\n\u003cli aria-level=\"1\"\u003e\n\u003cb\u003eUser instructions\u003c\/b\u003e insert\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-end=\"2082\" data-start=\"2057\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3 data-end=\"2082\" data-start=\"2057\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3 data-end=\"2082\" data-start=\"2057\"\u003eImportant Information\u003c\/h3\u003e\n\u003cul data-end=\"2441\" data-start=\"2083\"\u003e\n\u003cli data-end=\"2145\" data-start=\"2083\"\u003eConsultation with a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2320\" data-start=\"2288\"\u003elicensed healthcare provider\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis essential prior to any consideration of use\u003c\/li\u003e\n\u003cli data-end=\"2441\" data-start=\"2368\"\u003e\n\u003cp data-end=\"2441\" data-start=\"2370\"\u003eResults observed in clinical trials may not reflect real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2446\" data-start=\"2443\"\u003e\n\u003ch3 data-end=\"2481\" data-start=\"2448\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp data-end=\"2588\" data-start=\"2482\"\u003eThis product is supplied strictly on an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2550\" data-start=\"2522\"\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul data-end=\"3029\" data-start=\"2590\"\u003e\n\u003cli data-end=\"2671\" data-start=\"2590\"\u003e\n\u003cp data-end=\"2671\" data-start=\"2592\"\u003eYou have independently researched this product and its investigational status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2748\" data-start=\"2672\"\u003e\n\u003cp data-end=\"2748\" data-start=\"2674\"\u003eYou have consulted, or will consult, a qualified healthcare professional\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2943\" data-start=\"2860\"\u003e\n\u003cp data-end=\"2943\" data-start=\"2862\"\u003eThe seller provides\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2941\" data-start=\"2882\"\u003eno medical advice, treatment claims, or dosing guidance\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3029\" data-start=\"2944\"\u003e\n\u003cp data-end=\"3029\" data-start=\"2946\"\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"3029\" data-start=\"2950\"\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43251185516657,"sku":null,"price":1300.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-05-18125229.png?v=1779101437"},{"product_id":"bodypharm-impamorelin-5mg-self-mix","title":"BodyPharm Impamorelin 5mg Self Mix","description":"\u003cp\u003e\u003cstrong\u003eBP Ipamorelin 5 mg,\u003cspan\u003e \u003c\/span\u003e\u003c\/strong\u003eis a synthetic peptide known for its potential therapeutic benefits in promoting the release of growth hormone.\u003c\/p\u003e\n\u003cp\u003eBelow, we explore the advantages, potential side effects, detailed dosage instructions, and half-life associated with Ipamorelin.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBenefits of Ipamorelin (5mg):\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eGrowth Hormone Release:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eIpamorelin ? specifically designed to stimulate the release of growth hormone (GH) from the pituitary gland. This can lead to several potential benefits, including:\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMuscle Growth:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eIncreased GH levels may promote muscle growth and hypertrophy, making it a popular choice among athletes and bodybuilders.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFat Metabolism:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eIpamorelin may aid in fat loss by enhancing the body’s ability to metabolize fat for energy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRecovery:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eUsers have reported accelerated recovery from intense physical activities or workouts, potentially reducing the risk of overtraining.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImproved Sleep:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eSome individuals experience better sleep quality with Ipamorelin use.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eDosage Instructions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDosage instructions for Ipamorelin 5 mg can vary based on individual goals and healthcare provider recommendations. Typically, people administer it through subcutaneous injections. Here are general guidelines:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eCommon dosages range from 100 to 300 micrograms (?g) per injection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInjection Frequency:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eOften injected 1-3 times a day to maintain elevated GH levels. Some users prefer to administer injections before or after workouts.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDuration of Use:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eCycles of Ipamorelin use can vary but are often several weeks to months in duration.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIt is crucial to consult with a qualified healthcare provider for precise dosage instructions tailored to individual health needs and goals.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIpamorelin is generally considered safe and well-tolerated. However, as with any substance, it may have potential side effects, although these are typically mild and infrequent. Potential side effects may include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInjection Site Reactions:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eMild irritation, redness, or swelling at the injection site can occur.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHunger:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eUsers often report an increase in appetite, sometimes referred to as ?ghrelin surge,? after using Ipamorelin. This effect can be managed through dietary choices.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHeadache:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eSome individuals may experience mild headaches, although these are infrequent.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIt’s essential to note that side effects can vary among individuals, and severe adverse effects are rare.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHalf-Life:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIpamorelin 5 has a relatively short half-life, estimated to be approximately 2 hours. This means that the body rapidly clears it after administration. To maintain stable levels of the peptide in the bloodstream, you will need multiple daily injections to maintain consistent GH elevation throughout the day.\u003c\/p\u003e\n\u003cp\u003eIn summary, Ipamorelin (5mg) is a synthetic peptide with potential benefits in promoting growth hormone release, muscle growth, fat metabolism, recovery, and sleep improvement. Generally considered safe, with mild and infrequent side effects. Proper dosage instructions and consultation with a healthcare provider are essential for individuals considering Ipamorelin as part of their regimen.\u003c\/p\u003e\n\u003ch3 data-start=\"2057\" data-end=\"2082\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3 data-start=\"2057\" data-end=\"2082\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3 data-start=\"2057\" data-end=\"2082\"\u003eImportant Information\u003c\/h3\u003e\n\u003cul data-start=\"2083\" data-end=\"2441\"\u003e\n\u003cli data-start=\"2083\" data-end=\"2145\"\u003eConsultation with a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2288\" data-end=\"2320\"\u003elicensed healthcare provider\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis essential prior to any consideration of use\u003c\/li\u003e\n\u003cli data-start=\"2368\" data-end=\"2441\"\u003e\n\u003cp data-start=\"2370\" data-end=\"2441\"\u003eResults observed in clinical trials may not reflect real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"2443\" data-end=\"2446\"\u003e\n\u003ch3 data-start=\"2448\" data-end=\"2481\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp data-start=\"2482\" data-end=\"2588\"\u003eThis product is supplied strictly on an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2522\" data-end=\"2550\"\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul data-start=\"2590\" data-end=\"3029\"\u003e\n\u003cli data-start=\"2590\" data-end=\"2671\"\u003e\n\u003cp data-start=\"2592\" data-end=\"2671\"\u003eYou have independently researched this product and its investigational status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2672\" data-end=\"2748\"\u003e\n\u003cp data-start=\"2674\" data-end=\"2748\"\u003eYou have consulted, or will consult, a qualified healthcare professional\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2860\" data-end=\"2943\"\u003e\n\u003cp data-start=\"2862\" data-end=\"2943\"\u003eThe seller provides\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2882\" data-end=\"2941\"\u003eno medical advice, treatment claims, or dosing guidance\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2944\" data-end=\"3029\"\u003e\n\u003cp data-start=\"2946\" data-end=\"3029\"\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2950\" data-end=\"3029\"\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43251186368625,"sku":null,"price":600.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-05-18125355.png?v=1779101520"},{"product_id":"bodypharm-tb500-5mg-self-mix","title":"BodyPharm TB500 5mg Self Mix","description":"\u003cp\u003eBP TB500 5 mg, is a synthetic peptide renowned for its potential therapeutic benefits in tissue repair, injury recovery, and overall well-being.\u003c\/p\u003e\n\u003cp\u003eBelow, we delve into the advantages, potential side effects, detailed dosage instructions, and half-life associated with TB500.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBenefits of TB500 (5mg):\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eTissue Repair:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eCelebrated for its remarkable ability to promote tissue repair and regeneration. This includes muscles, tendons, ligaments, and even skin.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInjury Recovery:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eUsers often turn to TB500 to accelerate the recovery process from various injuries, such as strains, sprains, and overuse injuries.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduced Inflammation:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eTB500 may have anti-inflammatory properties, potentially aiding in reducing inflammation and discomfort associated with injuries.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImproved Flexibility:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eSome individuals have reported increased flexibility and mobility after TB500 use, particularly in cases of chronic stiffness.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eDosage Instructions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDosage instructions for TB500 (5mg) can vary based on individual needs and healthcare provider recommendations. It is typically administered via subcutaneous injections. Here are general guidelines:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eLoading Phase:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eDuring the initial phase, users may inject 2.5 to 5mg per week for four to six weeks to achieve desired results. This phase is often referred to as the “loading phase.”\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMaintenance Phase:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eAfter achieving the desired improvements, users may switch to a “maintenance phase,” where they inject 2.5 to 5mg every two weeks.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInjury-Specific Use:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eIn some cases, users may choose to inject TB500 directly into the injured area for more targeted treatment. Consultation with a qualified healthcare provider is essential for this approach.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIt is imperative to consult with a qualified healthcare provider for precise dosage instructions tailored to individual health needs and goals.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGenerally considered safe and well-tolerated, with minimal reported side effects. However, as with any substance, it may have potential side effects, although these are typically mild and infrequent. Potential side effects may include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInjection Site Reactions:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eMild irritation, redness, or swelling at the injection site can occur, but these effects are usually transient.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNausea:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eSome individuals may experience mild nausea, although this is infrequent.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFatigue:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eSome users have reported mild fatigue, which may be temporary.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIt’s important to note that side effects can vary among individuals, and severe adverse effects are rare.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHalf-Life:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTB500 has a relatively long half-life, estimated to be approximately 2.5 to 3.2 hours. This means that the peptide remains active in the body for this duration before its effects begin to diminish. Consequently, less frequent injections are often sufficient to maintain the desired therapeutic benefits.\u003c\/p\u003e\n\u003cp\u003eIn summary, TB500 (5mg) is a synthetic peptide with potential benefits in tissue repair, injury recovery, and reduced inflammation. Generally considered safe when administered under medical supervision. Proper dosage instructions and consultation with a healthcare provider are essential for individuals considering TB500 as part of their regimen.\u003c\/p\u003e\n\u003ch3 data-end=\"2082\" data-start=\"2057\"\u003eImportant Information\u003c\/h3\u003e\n\u003cul data-end=\"2441\" data-start=\"2083\"\u003e\n\u003cli data-end=\"2145\" data-start=\"2083\"\u003e\n\u003cp data-end=\"2145\" data-start=\"2085\"\u003eThis product is supplied in a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2145\" data-start=\"2115\"\u003elyophilised peptide format\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2367\" data-start=\"2266\"\u003e\n\u003cp data-end=\"2367\" data-start=\"2268\"\u003eConsultation with a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2320\" data-start=\"2288\"\u003elicensed healthcare provider\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis essential prior to any consideration of use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2441\" data-start=\"2368\"\u003e\n\u003cp data-end=\"2441\" data-start=\"2370\"\u003eResults observed in clinical trials may not reflect real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2446\" data-start=\"2443\"\u003e\n\u003ch3 data-end=\"2481\" data-start=\"2448\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp data-end=\"2588\" data-start=\"2482\"\u003eThis product is supplied strictly on an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2550\" data-start=\"2522\"\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul data-end=\"3029\" data-start=\"2590\"\u003e\n\u003cli data-end=\"2671\" data-start=\"2590\"\u003e\n\u003cp data-end=\"2671\" data-start=\"2592\"\u003eYou have independently researched this product and its investigational status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2748\" data-start=\"2672\"\u003e\n\u003cp data-end=\"2748\" data-start=\"2674\"\u003eYou have consulted, or will consult, a qualified healthcare professional\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2943\" data-start=\"2860\"\u003e\n\u003cp data-end=\"2943\" data-start=\"2862\"\u003eThe seller provides\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2941\" data-start=\"2882\"\u003eno medical advice, treatment claims, or dosing guidance\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3029\" data-start=\"2944\"\u003e\n\u003cp data-end=\"3029\" data-start=\"2946\"\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"3029\" data-start=\"2950\"\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43251189448817,"sku":null,"price":610.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-05-18125537.png?v=1779101650"},{"product_id":"bodypharm-bpc157-self-mix","title":"BodyPharm BPC157 Self Mix","description":"\u003cp\u003e\u003cstrong\u003eBP BPC 157 \u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a peptide with a growing reputation for its potential therapeutic benefits and limited side effects. Below, we explore the advantages, potential side effects, detailed dosage instructions, and half-life associated with BPC157.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBenefits of BPC157:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eTissue Healing:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eBPC157 may accelerate the healing of various tissues, including muscles, tendons, ligaments, and even organs. It promotes tissue regeneration and repair, which may help individuals recover from injuries more swiftly.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduced Inflammation:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eBPC157 exhibits anti-inflammatory properties, potentially mitigating the inflammation associated with injuries or certain medical conditions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePain Management:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eUsers have reported a reduction in pain and discomfort, particularly in cases of musculoskeletal injuries and joint issues.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGastrointestinal Health:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eBPC157 may contribute to the maintenance of gastrointestinal health by aiding in the repair of the gut lining and potentially alleviating digestive issues.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eDosage Instructions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDosage instructions for BPC 157 can vary based on individual needs and the advice of a healthcare provider. BPC157 is typically administered via subcutaneous or intramuscular injections. Here are general guidelines:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eCommon dosages range from 250 to 500 micrograms (µg) per day, divided into multiple injections.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInjection Frequency:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eTypically, a user administers BPC 157 5 mg injections once or twice a day.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDuration of Use:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eThe duration of use may vary, but healthcare providers often recommend using BPC 157 for several weeks to months, followed by periods of rest.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIt is crucial to consult with a qualified healthcare provider before starting a BPC157 regimen to determine the appropriate dosage and duration of use based on individual health needs.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBPC 157 is generally considered safe and well-tolerated. However, like any substance, it may have potential side effects, which are typically mild and infrequent. These may include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInjection Site Reactions:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eUsers may experience minor irritation, redness, or swelling at the injection site.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGastrointestinal Issues:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eSome individuals have reported mild digestive discomfort, but this is relatively rare.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergic Reactions:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eAlthough rare, allergic reactions are possible, so users should monitor for signs such as hives or difficulty breathing.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIt’s essential to remember that side effects can vary among individuals, and severe adverse effects are uncommon.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHalf-Life:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBPC157 has a relatively short half-life, estimated to be approximately 2-3 hours. This means that the body rapidly metabolizes and clears it. As a result, healthcare providers typically recommend multiple daily injections to maintain consistent levels of BPC157 in the bloodstream.\u003c\/p\u003e\n\u003cp\u003eIn summary, BPC157 (5mg) is a peptide with potential therapeutic benefits, particularly in tissue healing, inflammation reduction, pain management, and gastrointestinal health. Limited side effects can occur, but it is generally considered safe. Proper dosage instructions and guidance from a healthcare provider are crucial for those considering BPC157 as part of their treatment regimen.\u003c\/p\u003e\n\u003ch3 data-end=\"2082\" data-start=\"2057\"\u003eImportant Information\u003c\/h3\u003e\n\u003cul data-end=\"2441\" data-start=\"2083\"\u003e\n\u003cli data-end=\"2145\" data-start=\"2083\"\u003e\n\u003cp data-end=\"2145\" data-start=\"2085\"\u003eThis product is supplied in a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2145\" data-start=\"2115\"\u003elyophilised peptide format\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2367\" data-start=\"2266\"\u003e\n\u003cp data-end=\"2367\" data-start=\"2268\"\u003eConsultation with a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2320\" data-start=\"2288\"\u003elicensed healthcare provider\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis essential prior to any consideration of use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2441\" data-start=\"2368\"\u003e\n\u003cp data-end=\"2441\" data-start=\"2370\"\u003eResults observed in clinical trials may not reflect real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2446\" data-start=\"2443\"\u003e\n\u003ch3 data-end=\"2481\" data-start=\"2448\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp data-end=\"2588\" data-start=\"2482\"\u003eThis product is supplied strictly on an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2550\" data-start=\"2522\"\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul data-end=\"3029\" data-start=\"2590\"\u003e\n\u003cli data-end=\"2671\" data-start=\"2590\"\u003e\n\u003cp data-end=\"2671\" data-start=\"2592\"\u003eYou have independently researched this product and its investigational status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2748\" data-start=\"2672\"\u003e\n\u003cp data-end=\"2748\" data-start=\"2674\"\u003eYou have consulted, or will consult, a qualified healthcare professional\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2943\" data-start=\"2860\"\u003e\n\u003cp data-end=\"2943\" data-start=\"2862\"\u003eThe seller provides\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2941\" data-start=\"2882\"\u003eno medical advice, treatment claims, or dosing guidance\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3029\" data-start=\"2944\"\u003e\n\u003cp data-end=\"3029\" data-start=\"2946\"\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"3029\" data-start=\"2950\"\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43251193806961,"sku":null,"price":750.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-05-18125704.png?v=1779101728"}],"url":"https:\/\/vitalitylab.co.za\/collections\/body-pharm.oembed","provider":"Vitality Lab","version":"1.0","type":"link"}